Cargando…
Role of Glutathione in the Regulation of Cisplatin Resistance in Cancer Chemotherapy
Three mechanisms have been proposed for the role of glutathione (GSH) in regulating cisplatin (CDDP) sensitivities that affects its ultimate cell-killing ability: (i) GSH may serve as a cofactor in facilitating multidrug resistance protein 2- (MRP2-) mediated CDDP efflux in mammalian cells, since MR...
Autores principales: | Chen, Helen H. W., Kuo, Macus Tien |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2946579/ https://www.ncbi.nlm.nih.gov/pubmed/20885916 http://dx.doi.org/10.1155/2010/430939 |
Ejemplares similares
-
Targeting the Copper Transport System to Improve Treatment Efficacies of Platinum-Containing Drugs in Cancer Chemotherapy
por: Kuo, Macus Tien, et al.
Publicado: (2021) -
Regulation of the high-affinity copper transporter (hCtr1) expression by cisplatin and heavy metals
por: Liang, Zheng Dong, et al.
Publicado: (2013) -
C‐Jun N‐terminal kinase signalling pathway in response to cisplatin
por: Yan, Dong, et al.
Publicado: (2016) -
Improving radiotherapy in cancer treatment: Promises and challenges
por: Chen, Helen H.W., et al.
Publicado: (2017) -
Targeted cellular metabolism for cancer chemotherapy with recombinant arginine-degrading enzymes
por: Kuo, Macus Tien, et al.
Publicado: (2010)